Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel
Public ClinicalTrials.gov record NCT06617572. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Expanded Access Protocol for Product Which Does Not Conform to the TECELRA® (Afamitresgene Autoleucel, Suspension for Intravenous Infusion) Commercial Release Specification
Study identification
- NCT ID
- NCT06617572
- Recruitment status
- Available
- Study type
- Expanded access
- Phase
- Not listed
- Lead sponsor
- USWM CT, LLC
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Non-conforming afamitresgene autoleucel Genetic
Genetic
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Feb 8, 2026
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Arizona | Phoenix | Arizona | 85259 | Available |
| Stanford Hospital and Clinics | Stanford | California | 94305 | Available |
| Mayo Florida | Jacksonville | Florida | 32224 | Available |
| Moffit Cancer Center | Tampa | Florida | 33612 | Available |
| Northwestern University Feinberg School of Medicine | Chicago | Illinois | 60601 | Available |
| Massachusetts General Hospital | Boston | Massachusetts | 02144 | Available |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | Available |
| Mayo Rochester | Rochester | Minnesota | 55905 | Available |
| Memorial Sloan Kettering Cancer Centre | New York | New York | 10065 | Available |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | Available |
| MD Anderson Cancer Center | Houston | Texas | 77030 | Available |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06617572, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 8, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06617572 live on ClinicalTrials.gov.